Literature DB >> 1666368

Protective effects of R 56 865 against ischemic damage in the isolated rabbit heart.

G Vandeplassche1, F Thoné, M Borgers.   

Abstract

We examined the role of calcium in the pathogenesis of ischemic cardiac cell death in the isolated working rabbit heart subjected to normothermic global ischemia followed by reperfusion. Apart from measurements of cardiodynamic function and ultrastructural examination, we also used a cytochemical procedure to localize exchangeable calcium pools at the ultrastructural level. The effects of verapamil (1.5 x 10(-8) M, 3 x 10(-8) M) (high affinity for L-type calcium channels) were compared with those of R 56 865 (4 x 10(-7) M) (Ca2+ overload blocker with low affinity for the L-type calcium channels). A severe depression of cardiac function was observed after solvent or verapamil pretreatment and 25 min of ischemia followed by reperfusion. R 56 865 treatment resulted in a significantly improved postischemic recovery when compared to solvent and verapamil treatment groups. The ultrastructural and cytochemical results corroborated the hemodynamic findings. In solvent and verapamil-treated hearts, irreversible damage was observed mainly in mid- and endocardial areas. Ultrastructural changes were accompanied by shifts in calcium localization: i.e. loss of sarcolemmal calcium binding capacity, accumulation of calcium precipitate in the mitochondria. In the R 56 865 treatment group, damage was limited to some cells scattered in the midcardial areas. In conclusion, R 56 865, which has little affinity for the slow channels was highly effective in protecting against ischemic damage, indicating that, in this experimental set-up, the calcium responsible for cellular Ca2+ overload is not entering via L-type calcium channels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666368     DOI: 10.1016/0014-2999(91)90302-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  The negative inotropic and chronotropic effects of intravenous R 56865 during percutaneous transluminal coronary angioplasty.

Authors:  A J Pijl; H B Van Wezel; J J Koolen; J J Piek; K Koch; A Swaan; G K David; C A Visser; P A Van Zwieten
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

2.  Effects of R 56865 on postischemic ventricular function in isolated rat working heart preparations obtained from healthy, diabetic and hypertensive animals.

Authors:  A J Pijl; M G Hendriks; K L Kam; M Paffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

3.  R56865 is antifibrillatory in reperfused ischemic guinea-pig hearts, even when given only during reperfusion.

Authors:  E Scheufler; A Mozes; I Guttmann; B Wilffert
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.